DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 2Accord healthcare
03 1Aurobindo Pharma Limited
04 23Boehringer Ingelheim GmbH
05 2Captavis Biocare
06 1Cipla
07 1Glenmark Pharmaceuticals
08 2Intas Pharmaceuticals
09 2Lotus Pharmaceutical
10 2Olon S.p.A
11 2TEVA PHARMACEUTICALS DEVELOPMENT INC
01 2CAP
02 5CAPSULE
03 8CAPSULE;ORAL
04 2Caps
05 2Capsule
06 5Capsule, soft
07 2KAPSEL, MJUK
08 1Nintedanib 100Mg 60 Units Oral Use
09 1Nintedanib 150Mg 60 Units Oral Use
10 2Oral Solid Dosage Form
11 2SOFT CAPSULE
12 2Soft Gel
13 2Soft Gelatin Capsule
14 4Blank
01 1Available Dossier- US-EU-RoW
02 2Lead Market Dossiers- Under Development
03 2Originator
04 2RX
05 33Blank
01 9NINTEDANIB
02 4OFEV
03 12Ofev
04 1Ofev 100 mg
05 1Ofev 150 mg
06 5Vargatef
07 8Blank
01 4Australia
02 2Canada
03 6India
04 4Italy
05 5Norway
06 2South Africa
07 4Sweden
08 2Switzerland
09 11USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date :
Application Number : 212732
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date :
Application Number : 212732
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date :
Application Number : 215123
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OFEV
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2014-10-15
Application Number : 205832
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OFEV
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2014-10-15
Application Number : 205832
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Ofev
Dosage Form : SOFT CAPSULE
Dosage Strength : 150 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Ofev
Dosage Form : SOFT CAPSULE
Dosage Strength : 100 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Vargatef
Dosage Form : KAPSEL, MJUK
Dosage Strength : 100 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Vargatef
Dosage Form : KAPSEL, MJUK
Dosage Strength : 150 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Ofev
Dosage Form : Nintedanib 100Mg 60 Units Oral Use
Dosage Strength : 1x60 soft cps 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ofev
Dosage Form : Nintedanib 150Mg 60 Units Oral Use
Dosage Strength : 1x60 soft cps 150 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Ofev
Dosage Form : Capsule, soft
Dosage Strength : 100 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 212609
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date :
Application Number : 212555
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 216915
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 216915
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 219371
Regulatory Info :
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number : 219371
Regulatory Info :
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
